Table 4 |
|||||
|
Susceptibility of P. falciparum to antimalarials in Burkina Faso. |
|||||
|
Year |
Drugs tested |
Study sites |
Urban/Rural |
Authors |
Failure rate In vivo |
|
|
|||||
|
1982–1986 |
CQ (in vitro & in vivo) |
Koudougou |
Urban |
[36] |
First case found |
|
1988–1989 |
CQ |
Koudougou Zaghtouli Dori Banfora Fada N'Gourma |
Urban Rural Urban Rural Rural |
[37] |
25% |
|
1988 |
CQ |
Zaghtouli |
Rural |
[38] |
18.7% |
|
1989 |
CQ |
Dapelgo |
Rural |
[38] |
20.2% |
|
1982–1991 |
CQ, SP, quinine, MP (in vitro) |
Ouagadougou Bobo-Dioulasso |
Urban |
[39] |
6–15.8 % |
|
1990–1992 |
CQ, SP (in vitro), quinine, halofantrine hydrochloride MP, |
Ouagadougou and its neighbouring villages |
Urban Rural |
[22, 40-42] |
CQ & SP: 8.1–24.4% Others: 0% |
|
1993 |
CQ |
Ouagadougou |
Urban |
[43] |
25% |
|
1995–1996 |
CQ, quinine, MP (in vitro) |
Bobo-Dioulasso |
Urban |
[44] |
CQ: 19–20% M:2–9.6% |
|
1992–1998 |
CQ, AQ, quinine, halofantrine MP |
Ouagadougou |
Urban |
[45] |
AQ:4.3% & 2.2 % in 1997 CQ:8.5% in 1992, CQ:20% in 1994 H: 7.9% in 1997 (in vitro) MP: 0% in 1997 (in vitro) Q: 0.9% in 1995 MP+H:7.6% in 1997 |
|
1999–2002 |
CQ & SP |
Bobo-Dioulasso |
Urban |
[46] |
CQ:18% SP: < 1% |
|
|
|||||
|
AQ: Amodiaquine CQ: Chloroquine MP: Mefloquine SP: Sulfadoxine/pyrimethamine |
|||||
|
Wang et al. Malaria Journal 2005 4:43 doi:10.1186/1475-2875-4-43 |
|||||
